MoneyWorks4Me

Norris Medicines informs about demise of independent director

24 May 2021 Evaluate
In compliance with the regulation 30 and 68(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about the sad demise of Sanjivkumar Shah, Independent Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1736.60
Dr. Reddys Labs. 1241.45
Cipla 1318.20
Lupin 1943.20
Zydus Lifesciences 1113.95
View more..